March 16, 2026
Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate name Genesis Healthcare Co.), one of Japan’s leading genetic testing companies, today announce an international collaboration to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan. In [...]
Inocras and NDS Partner to Deliver Clinical-Scale Whole-Genome Cancer Analytics in the Cloud
March 12, 2026
Partnership combines Inocras’s clinical grade cancer diagnostics and analytics solutions with NDS’s cloud and secure data environment infrastructure SAN DIEGO & SEOUL, South Korea -- Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced a strategic partnership with NDS Corporation (NDS), a South Korean [...]
Bettersize Instruments Launches Bettersizer 2600 Plus: All-in-One Particle Size and Shape Analyzer
March 12, 2026
Introducing the Bettersizer 2600 Plus, a combition of laser diffraction and dynamic imaging to deliver advanced particle size and shape analysis in one system. COSTA MESA, CA, UNITED STATES — Bettersize Instruments, a global leader in particle characterization technologies, announced the launch of the Bettersizer 2600 Plus, a next-generation particle size and shape analyzer designed to [...]
March 12, 2026
The designation builds on the unit’s role as the first G4X Early Access Program site and supports broader global adoption of G4X. San Diego, CA and Boston, MA — Singular Genomics today announced that the Spatial Technologies Unit (STU) at Beth Israel Deaconess Medical Center (BIDMC), a Dana-Farber/Harvard Cancer Center (DF/HCC) Core Facility, has been designated a G4X™ Center of Excellence. The STU [...]
March 12, 2026
New platform eliminates hydrodynamic shear stress and scales isometrically from 50 mL to 250 mL, targeting a reduction in CAPEX and media costs. SAN FRANCISCO -- Stämm launched the High-Throughput Bioprocessor (HTB), an automated, single-use biomanufacturing platform for adherent and suspension cells. The HTB is engineered to eliminate the infrastructure constraints that slow research and development, and [...]
March 11, 2026
Laboratories running wastewater surveillance, bloodstream pathogen detection, or urine-based STI screening no longer need to choose between sample volume and automation. SwiftXtractor™ SL processes up to 40 mL in a single run, replacing manual concentration steps that cost time, introduce variability, and limit throughput. Compact, portable, and ready for your bench. Hallbergmoos, Germany — [...]
University of Colorado Grants License to Cirena for RNA-Synthesis Technology
March 11, 2026
Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision BOULDER, CO – Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology, giving researchers scalable access to high purity 100-400nt RNA constructs for next-generation therapeutics. The agreement brings to market an approach developed [...]
March 11, 2026
Siemens brings world-class capabilities in industrial AI, digital twin technology, and engineering to DOE’s Genesis Mission, building on its longstanding collaboration Today, Siemens announced it has signed a Memorandum of Understanding (MOU) with the U.S. Department of Energy (DOE) to support the Genesis Mission, a federal initiative to modernize America’s scientific infrastructure and strengthen the [...]
Gore Expands Leadership in Membrane Chromatography with Next-Generation Affinity Solutions
March 11, 2026
W. L. Gore & Associates (Gore) is collaborating with customized ligand partners to introduce a new range of high-performance affinity membrane chromatography products. This initiative expands Gore’s presence in the bioprocessing industry beyond Protein A-based solutions, further advancing purification performance and scalability for biopharmaceutical manufacturers. NEWARK, Del. -- W. L. Gore & Associates, Inc. ("Gore"), [...]
Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis
March 10, 2026
Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. - Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in [...]

